Salman Basrai^1*, Robert Kridel², Mehran Bakhtiari^2*, Dennis D. H. Kim², Fernando L. Scolari^3*, Filio Billia^3*, Andrea Arruda^2*, Mark D. Minden^2* and Sagi Abelson^1*

¹Ontario Institute for Cancer Research, Toronto, Canada
²Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
³Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Canada

Marco M. Buttigieg, BSc^1*, Caitlyn Vlasschaert, MD, PhD^2* and Michael J. Rauh, MD, PhD¹

¹Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada
²Department of Medicine, Queen’s University, Kingston, ON, Canada

Matthew Jenkins, BS¹, Yunli Chu, BS², Sajesan Aryal³, Xinyue Zhou, BPharm^4*, Kirsten Dickerson, BS^2*, Rebecca Dubin, BS^5*, Chad R Potts, BS^6*, Valeriya Kuznetsova⁷, Alana Franceski^8*, Paran Goel^7*, Stanley C Lee, PhD⁹, Rui Lu, PhD¹⁰, Robert Welner, PhD¹¹ and P. Brent Ferrell Jr., MD⁶

¹Department of Pharmacology, Vanderbilt University, Nashville, TN
²Vanderbilt University Medical Center, Nashville, TN
³O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL
⁴Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁵Vanderbilt University, Nashville, TN
⁶Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
⁷Division of Hematology and Oncology and O'neal Comprehensive Cancer Center, University of Alabama-Birmingham, Birmingham, AL
⁸Division of Hematology and Oncology and O'Neal Comprehensive Cancer Center, University of Alabama-Birmingham, Birmingham, AL
⁹Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
¹⁰Department of Medicine, Division of Hematology/Oncology, University of Alabama At Birmingham, Birmingham, AL
¹¹Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

Nicholas Bernstein, BA^1*, Michael Spencer Chapman, MBBS^2*, Kudzai Nyamondo, BSc, MSc^2*, Zhenghao Chen, PhD^3*, Nicholas Williams, PhD^2*, Emily Mitchell, FRCPath^2*, Peter Campbell, PhD^4*, Robert L Cohen, MD³ and Jyoti Nangalia, MBBChir PhD^2*

¹Current affiliation: TenSixteen Bio, Calico Life Sciences LLC, South San Francisco
²Wellcome Sanger Institute, Hinxton, United Kingdom
³Calico Life Sciences LLC, South San Francisco, CA
⁴Wellcome Trust Sanger Institute, Cambridge UK, Cambridge, ENG, GBR

Serine Avagyan, MD, PhD¹, Song Yang^2*, Brandon Gheller, PhD^3* and Leonard I. Zon, MD⁴

¹Department of Pediatrics, University of California, San Francisco, San Francisco, CA
²Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA
³Boston Children's Hospital, Boston
⁴Harvard Medical School, Boston, MA

Jean Pegliasco^1*, David Fandrei^1*, Florence Pasquier, MD, PhD^1*, Nathalie Ibrahim^2*, Maria Kfoury^1*, Guillemette Imbert-De-Tremiolles^1*, Nourhan Lizziek^1*, Céline Berthon, MD^3*, Mael Heiblig^4*, Delphine Lebon^5*, Ambroise Marcais, MD^6*, Mathieu Meunier, MD, PhD^7*, Ahmad Aljijakli^8*, Emilie Lemasle, MD^9*, Sylvain Chantepie, MD^10*, Cécile Pautas, MD^11*, Pierre-Yves Dumas, MD, PhD^12*, Stephanie Haiat^13*, Cyril Quivoron^1*, Ileana antony-Debre^14*, Sophie Cotteret^1*, Raphael Itzykson¹⁵, Hervé Dombret^16*, Nicolas Duployez, PharmD, PhD^17*, Nathalie Droin^1*, Christophe Marzac^1*, Elsa Bernard^1* and Jean-Baptiste Micol, MD¹⁸

¹Gustave Roussy, VILLEJUIF, France
²CH Boulogne-sur-Mer, Boulogne-sur-Mer, France
³Hematology Department, CHRU Lille, Lille, France
⁴Hematology Department, Hôpital Lyon Sud, Vourles, Rhône Alpes, France
⁵Hematology Department, CHU Amiens, Amiens, France
⁶Hopital Necker, Paris, France
⁷Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
⁸CH Argenteuil, Argenteuil, France
⁹Hematology Department, Centre Henri Becquerel, Rouen, France
¹⁰Institut d'Hématologie, CHU de Caen, Caen, France
¹¹Hôpital Henri Mondor, Hematology Department, AP-HP, Créteil, France
¹²Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
¹³Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
¹⁴INSERM UMR1287, New York, NY
¹⁵Hematology Department, St Louis Hospital, Paris, France
¹⁶Saint Louis Hospital, University of Paris, Paris, FRA
¹⁷Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
¹⁸Institut Gustave Roussy, Villejuif, FRA

Waseem Nasr, PhD^1,2, Juying Xu^1,2* and Marie-Dominique Filippi, PhD^1,2

¹Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
²University of Cincinnati College of Medicine, Cincinnati, OH

Nakisha D Williams, MBBS^1*, Arda Durmaz^1*, Carlos Bravo-Perez, MD^1*, Yasuo Kubota, MD, PhD^2*, Megan Reynold^1*, Michaela Witt^1*, Luca Guarnera, MD^1*, Morgan Ferrel^1*, Aashray Mandala, BS^1*, Naomi Kawashima, MD, PhD^1*, Carmelo Gurnari, MD¹, Valeria Visconte, PhD¹ and Jaroslaw P. Maciejewski, M.D., Ph.D., FACP¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Beachwood, OH

Murtaza S. Nagree, PhD^1*, Andy G.X. Zeng^1,2, Angelica Varesi, MSc^1,2*, Isabel N.X. Lim^1*, Sayyam Shah^1*, Hyerin Kim^1*, Liqing Jin, MD^1*, Mason Boulanger^1*, John E. Dick, PhD^1,2* and Stephanie Z. Xie, PhD³

¹Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
³University Health Network, Toronto, ON, Canada

Shyam Ajay Patel, MD, PhD^1*, William K Gerber^2*, Rena Zheng, MD, PhD², Shrinkhala Khanna, MD², Lloyd Hutchinson^2*, Jan Cerny, MD, PhD², Brandon Dasilva, MD³, Tian Y. Zhang, MD, PhD⁴, Salwa Khedr, MD^2*, William Selove^5*, Bruce Woda, MD², Gregory A Abel, MD, MPH⁶, Patricia Minehart Miron, PhD^2*, Anne Higgins^2* and Jonathan M. Gerber, MD²

¹Department of Medicine - Hematology/Oncology, UMass Chan Medical School, Worcester, MA
²UMass Chan Medical School, Worcester, MA
³Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁴Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁵UMass Memorial Medical Center, Whitinsville, MA
⁶DFCI, Boston, MA

Peter D Lyon, BS^1,2, Luis Nivelo, BS^3*, Byron Fang, MS^4*, Victoria Strippoli, BS^4*, Praveen Singh, PhD^5*, Sabita Roy, PhD^5*, Alejandro Villarino, PhD^3* and Luisa Cimmino, PhD, BSc^1,6

¹Cancer Epigenetics Program, Sylvester Comprehensive Cancer Center, University of Miami-Miller School of Medicine, Miami, FL
²Medical Scientist Training Program, University of Miami-Miller School of Medicine, Miami Beach, FL
³Department of Microbiology & Immunology, University of Miami-Miller School of Medicine, Miami, FL
⁴Department of Biochemistry & Molecular Biology, University of Miami-Miller School of Medicine, Miami, FL
⁵Department of Surgery, University of Miami-Miller School of Medicine, Miami, FL
⁶University of Miami-Miller School of Medicine, Miami, FL

Alexander Marr, BS^1*, Madeline Halpin, BS^1*, Dominique Corbin, BS^1*, Britten Gordon, BS¹, Samon Benrashid, BS^1*, Ethan C. Whipp, MSc^1*, Mehdi Gharghabi, PharmD^1*, Jean Truxall^1*, Olivia Cahn^1*, Kristin L Koenig, MD², Karilyn T. Larkin, MD², Jennifer A. Woyach, MD³, Rosa Lapalombella, PhD¹ and Nicole R. Grieselhuber, MD, PhD¹

¹The Ohio State University, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
³The Ohio State University Comprehensive Cancer Center, Columbus, OH